REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 112 filers reported holding REPLIMUNE GROUP INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,796,541 | -58.8% | 689,453 | -44.1% | 0.02% | -57.1% |
| Q2 2023 | $28,635,461 | +150.7% | 1,233,224 | +90.6% | 0.06% | +133.3% |
| Q1 2023 | $11,424,041 | +231.8% | 646,888 | +411.1% | 0.02% | +200.0% |
| Q4 2022 | $3,442,621 | +906.6% | 126,567 | +528.3% | 0.01% | +700.0% |
| Q1 2022 | $342,000 | -30.2% | 20,143 | -5.4% | 0.00% | -66.7% |
| Q3 2020 | $490,000 | +40.0% | 21,291 | +51.2% | 0.00% | +50.0% |
| Q2 2020 | $350,000 | +97.7% | 14,086 | +14.4% | 0.00% | +100.0% |
| Q4 2019 | $177,000 | – | 12,311 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 5,344,971 | $122,395,000 | 33.11% |
| Corriente Advisors, LLC | 512,500 | $11,798,000 | 5.98% |
| Bain Capital Life Sciences Investors, LLC | 2,122,415 | $48,858,000 | 4.55% |
| BVF INC/IL | 1,691,834 | $38,946,000 | 2.12% |
| Redmile Group, LLC | 3,330,999 | $76,680,000 | 1.41% |
| EMERALD ADVISERS, LLC | 891,761 | $20,528,000 | 0.84% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 823,989 | $18,968,000 | 0.84% |
| Penn Mutual Asset Management, LLC | 15,877 | $365,000 | 0.52% |
| EAM Global Investors LLC | 54,274 | $1,249,000 | 0.46% |
| Artal Group S.A. | 700,000 | $16,114,000 | 0.39% |